Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.
Avior Bio has raised $200K in total funding. The most recent round was Debt Financing. The last funding was announced in February 2023.
Avior Bio's investors include National Science Foundation, North Carolina Biotechnology Center.
Avior Bio is headquartered in Holly Springs, United States.
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.
Avior Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avior Bio — Funding & Investors." VCBacked, February 17, 2023, https://www.vcbacked.co/company/avior-bio. Accessed September 30, 2026.
VCBacked. (2023). Avior Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/avior-bio
{{cite web |title=Avior Bio — Funding & Investors |url=https://www.vcbacked.co/company/avior-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated